311 related articles for article (PubMed ID: 18223485)
21. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.
Wise LA; Palmer JR; Rowlings K; Kaufman RH; Herbst AL; Noller KL; Titus-Ernstoff L; Troisi R; Hatch EE; Robboy SJ
Obstet Gynecol; 2005 Jan; 105(1):167-73. PubMed ID: 15625159
[TBL] [Abstract][Full Text] [Related]
22. Cancer risk in men exposed in utero to diethylstilbestrol.
Strohsnitter WC; Noller KL; Hoover RN; Robboy SJ; Palmer JR; Titus-Ernstoff L; Kaufman RH; Adam E; Herbst AL; Hatch EE
J Natl Cancer Inst; 2001 Apr; 93(7):545-51. PubMed ID: 11287449
[TBL] [Abstract][Full Text] [Related]
23. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
25. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
[TBL] [Abstract][Full Text] [Related]
26. A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk.
Troisi R; Titus L; Hatch EE; Palmer JR; Huo D; Strohsnitter WC; Adam E; Ricker W; Hyer M; Hoover RN
J Clin Endocrinol Metab; 2018 Jan; 103(1):206-212. PubMed ID: 29069384
[TBL] [Abstract][Full Text] [Related]
27. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
28. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy.
Titus-Ernstoff L; Hatch EE; Hoover RN; Palmer J; Greenberg ER; Ricker W; Kaufman R; Noller K; Herbst AL; Colton T; Hartge P
Br J Cancer; 2001 Jan; 84(1):126-33. PubMed ID: 11139327
[TBL] [Abstract][Full Text] [Related]
29. Age at natural menopause in women exposed to diethylstilbestrol in utero.
Hatch EE; Troisi R; Wise LA; Hyer M; Palmer JR; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Adam E; Noller KL; Herbst AL; Robboy S; Hartge P; Hoover RN
Am J Epidemiol; 2006 Oct; 164(7):682-8. PubMed ID: 16887893
[TBL] [Abstract][Full Text] [Related]
30. Current perspective of diethylstilbestrol (DES) exposure in mothers and offspring.
Al Jishi T; Sergi C
Reprod Toxicol; 2017 Aug; 71():71-77. PubMed ID: 28461243
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune disease incidence among women prenatally exposed to diethylstilbestrol.
Strohsnitter WC; Noller KL; Troisi R; Robboy SJ; Hatch EE; Titus-Ernstoff L; Kaufman RH; Palmer JR; Anderson D; Hoover RN
J Rheumatol; 2010 Oct; 37(10):2167-73. PubMed ID: 20634240
[TBL] [Abstract][Full Text] [Related]
32. DES exposure and the aging woman: mothers and daughters.
Laitman CJ
Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
[TBL] [Abstract][Full Text] [Related]
33. Reproductive performance among DES exposed daughters compared with that of their mothers.
Kirkhope TG
Ohio State Med J; 1983 Nov; 79(11):867-9. PubMed ID: 6646562
[TBL] [Abstract][Full Text] [Related]
34. Prenatal exposure to diethylstilbestrol and the mother-daughter relationship.
Cahen F; Dubreuil E; Pons JC
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):181-7. PubMed ID: 8730622
[TBL] [Abstract][Full Text] [Related]
35. Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol.
Baird DD; Wilcox AJ; Herbst AL
J Clin Epidemiol; 1996 Feb; 49(2):263-6. PubMed ID: 8606329
[TBL] [Abstract][Full Text] [Related]
36. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH
APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
[TBL] [Abstract][Full Text] [Related]
37. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
[TBL] [Abstract][Full Text] [Related]
38. Diethylstilbestrol (DES) and breast cancer.
Malone KE
Epidemiol Rev; 1993; 15(1):108-9. PubMed ID: 8405194
[TBL] [Abstract][Full Text] [Related]
39. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study.
Klip H; Verloop J; van Gool JD; Koster ME; Burger CW; van Leeuwen FE;
Lancet; 2002 Mar; 359(9312):1102-7. PubMed ID: 11943257
[TBL] [Abstract][Full Text] [Related]
40. Prenatal diethylstilbestrol exposure and risk of diabetes, gallbladder disease, and pancreatic disorders and malignancies.
Troisi R; Hyer M; Titus L; Palmer JR; Hatch EE; Huo D; Aagaard KM; Strohsnitter WC; Hoover RN
J Dev Orig Health Dis; 2021 Aug; 12(4):619-626. PubMed ID: 33112220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
